论文部分内容阅读
目的:观察葛根索注射液对急性脑梗死的治疗疗效及安全性,方法:60例急性脑梗死患者随机分为两组,葛根素治疗组(A组)30例加5%葡萄糖溶液静脉滴注,每天1次,共14天;低分子右旋糖酐加复方丹参注射液(B组)30例,方法和疗程同A组。分别于治疗前、治疗7天及治疗14天后作神经功能缺损评分、结果:治疗后A组有效率86.7%,明显高于B组70.O%(P<0.05)。结论:葛根素治疗急性脑梗死能显著改善临床症状,且安全可靠,可作为急性脑梗死治疗的一种新选择
Objective: To observe the efficacy and safety of puerarin injection for acute cerebral infarction.Methods: Sixty patients with acute cerebral infarction were randomly divided into two groups: 30 patients in the puerarin group (group A) received intravenous infusion of 5% dextrose solution , 1 day, a total of 14 days; low molecular dextran plus compound Salvia injection (B group) 30 cases, methods and treatment with the A group. Neurological deficit scores were obtained before treatment, 7 days after treatment and 14 days after treatment, respectively. Results: After treatment, the effective rate in group A was 86.7%, which was significantly higher than that in group B (70.O%, P <0.05). Conclusion: Puerarin in the treatment of acute cerebral infarction can significantly improve the clinical symptoms, and safe and reliable, can be used as a new treatment for acute cerebral infarction